Why biotech is a boon for patients and investors
Joe Anderson, CEO of Arix Bioscience take on the future of biotech as seen in Spears article published 13th January 2020
Today we are at the forefront of a healthcare revolution, driven by advances in genetic analysis and molecular biology that are now creating real benefits for patients, says Joe Anderson
